AbbVie, DISCO Pharmaceuticals Team Up On AND-Gated Bispecific Solid Tumor Therapeutics Using DISCOtech Platform; Deal Carries $40M Upfront, Up To $2.5B Milestones

Benzinga
Benzingaで開く